Ocugen, Inc. (OCGN)
1.31
+0.08
(+6.50%)
USD |
NASDAQ |
Dec 11, 16:00
1.30
-0.01
(-0.76%)
After-Hours: 20:00
Ocugen Free Cash Flow: -53.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Belite Bio, Inc. | -- |
| MannKind Corp. | 42.74M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.92M |
| Cash from Investing (Quarterly) | -0.086M |
| Cash from Financing (Quarterly) | 18.51M |
| Free Cash Flow Per Share (Quarterly) | -0.0428 |
| Free Cash Flow to Equity (Quarterly) | -13.15M |
| Free Cash Flow to Firm (Quarterly) | -11.69M |
| Free Cash Flow Yield | -13.86% |